8-K - Kyverna Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Management Change

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment o

Management Change

$14.00B$40.0K$10.0K$7.5KDr. Miller in the same form as its standard form of indemnification and advancement agreement with its other directors. There are no family relationships between Dr. Miller and any director or executive officer of the Company

8.01

Other Events. On February 24, 2026, the Company issued a press release announcing the appointment of Dr. Miller and Mr. Emany to the Board. A copy of the press

Other Event

9.01

Financial Statements and Exhibits (d) Exhibits. Number Description 99.1 Press Release, dated February 24, 2026. 104 Cover Page Interactive Data File, formatted

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1